Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naive Subjects in Hunan Province, China

被引:13
作者
Zou Xiaobai [1 ]
Xi, Chen [1 ]
Tian, Hongping [2 ]
Williams, Ann B. [3 ]
Wang, Honghong [4 ]
He, Jianmei [1 ]
Zhen, Jun [1 ]
Chiarella, Jennifer [5 ]
Blake, Lisebeth A. [6 ]
Turenchalk, Gregory [6 ]
Kozal, Michael J. [5 ]
机构
[1] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China
[2] Yale China Assoc, New Haven, CT USA
[3] UCLA Sch Nursing, Los Angeles, CA USA
[4] Cent S Univ, Changsha, Hunan, Peoples R China
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] 454 Life Sci, Branford, CT USA
来源
PLOS ONE | 2014年 / 9卷 / 06期
关键词
REVERSE-TRANSCRIPTASE INHIBITORS; MINORITY POPULATIONS; HIV-1; VARIANTS; THERAPY; FAILURE; GENOME;
D O I
10.1371/journal.pone.0098740
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. Objective: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naive subjects in Hunan Province by deep sequencing. Methods: ART-naive subjects diagnosed in Hunan between 2010-2011 were evaluated by deep sequencing for low-frequency HIV variants possessing WHO TDRs to 1% levels. Mutations were scored using the HIVdb.stanford.edu algorithm to infer drug susceptibility. Results: Deep sequencing was performed on samples from 90 ART-naive subjects; 83.3% were AE subtype. All subjects had advanced disease (average CD4 count 134 cells/mm(3)). Overall 25.6%(23/90) of subjects had HIV with major WHO NRTI/NNRTI TDRs by deep sequencing at a variant frequency level >= 1%; 16.7%(15/90) had NRTI TDR and 12.2%(11/90) had a major NNRTI TDR. The majority of NRTI/NNRTI mutations were identified at variant levels <5%. Mutations were analyzed by HIVdb.stanford.edu and 7.8% of subjects had variants with high-level nevirapine resistance; 4.4% had high-level NRTI resistance. Deep sequencing identified 24(27.6%) subjects with variants possessing either a PI TDR or hivdb.stanford.edu PI mutation (algorithm value >= 15). 17(19.5%) had PI TDRs at levels >1%. Conclusions: ART-naive subjects from Hunan Province China infected predominantly with subtype AE frequently possessed HIV variants with WHO NRTI/NNRTI TDRs by deep sequencing that would affect the first line ART used in the region. Specific mutations conferring nevirapine high-level resistance were identified in 7.8% of subjects. The majority of TDRs detected were at variant levels <5% likely due to subjects having advanced chronic disease at the time of testing. PI TDRs were identified frequently, but were found in isolation and at low variant frequency. As PI/r use is infrequent in Hunan, the existence of PI mutations likely represent AE subtype natural polymorphism at low variant level frequency.
引用
收藏
页数:7
相关论文
共 43 条
  • [31] Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004
    Babic, Dunja Z.
    Zelnikar, Mojca
    Seme, Katja
    Vandamme, Anne-Mieke
    Snoeck, Joke
    Tomazic, Janez
    Vidmar, Ludvik
    Karner, Primoz
    Poijak, Mario
    VIRUS RESEARCH, 2006, 118 (1-2) : 156 - 163
  • [32] Comparative analysis of drug resistance mutations in the human immunodeficiency virus reverse transcriptase gene in patients who are non-responsive, responsive and naive to antiretroviral therapy
    Misbah, Mohammad
    Roy, Gaurav
    Shahid, Mudassar
    Nag, Nalin
    Kumar, Suresh
    Husain, Mohammad
    ARCHIVES OF VIROLOGY, 2016, 161 (05) : 1101 - 1113
  • [33] Development of HIV-1 Drug Resistance Through 144 Weeks in Antiretroviral-Naive Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With Lamivudine/Zidovudine and Efavirenz in Study GS-01-934
    Margot, Nicolas A.
    Enejosa, Jeff
    Cheng, Andrew K.
    Miller, Michael D.
    McColl, Damian J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (02) : 209 - 221
  • [34] Prevalence of Antiretroviral Drug Resistance Mutations and HIV-1 Subtypes among Newly-diagnosed Drug-naive Persons Visiting A Voluntary Testing and Counselling Centre in Northeastern South Africa
    Nwobegahay, Julius M.
    Bessong, Pascal O.
    Masebe, Tracy M.
    Mavhandu, Lufuno G.
    Iweriebor, Benson C.
    Selabe, Gloria
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2011, 29 (04) : 303 - 309
  • [35] Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide
    Margot, Nicolas A.
    Wong, Pamela
    Kulkarni, Rima
    White, Kirsten
    Porter, Danielle
    Abram, Michael E.
    Callebaut, Christian
    Miller, Michael D.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (06) : 920 - 927
  • [36] Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009–2011
    Hongxiong Guo
    Xiaoqin Xu
    Haiyang Hu
    Ying Zhou
    Haitao Yang
    Tao Qiu
    Gengfeng Fu
    Xiping Huan
    BMC Public Health, 15
  • [37] Prevalence and patterns of drug-resistance mutations among HIV-1 patients infected with CRF07BC strains in Sichuan province,China
    Ling Su
    Xia Zhou
    Dan Yuan
    Hong Yang
    Dongbing Wei
    Guangmin Qin
    Shu Liang
    Virologica Sinica, 2014, (04) : 237 - 241
  • [38] Increased prevalence of pretreatment drug resistance mutations in treatment-naïve people living with HIV-1 in Henan Province, China (2022/23)
    Liu, Jinjin
    Liu, Chunli
    Wang, Yanli
    Wei, Shuguang
    Ma, Jie
    Li, Yuanyuan
    Chen, Xuhui
    Zhao, Qingxia
    Huo, Yuqi
    INFECTION GENETICS AND EVOLUTION, 2023, 115
  • [39] Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009-2011
    Guo, Hongxiong
    Xu, Xiaoqin
    Hu, Haiyang
    Zhou, Ying
    Yang, Haitao
    Qiu, Tao
    Fu, Gengfeng
    Huan, Xiping
    BMC PUBLIC HEALTH, 2015, 15
  • [40] HIV-1 transmitted drug resistance-associated mutations and mutation co-variation in HIV-1 treatment-naive MSM from 2011 to 2013 in Beijing, China
    Jiao, Yang
    Li, Shuming
    Li, Zhenpeng
    Zhang, Zheng
    Zhao, Jianhong
    Li, Li
    Wang, Lijuan
    Yin, Qianqian
    Wang, Yan
    Zeng, Zhaoli
    Shao, Yiming
    Ma, Liying
    BMC INFECTIOUS DISEASES, 2014, 14